Todd Druley, MD, PhD
Chief Medical Officer

Vanee Pho, PhD
Senior Director, Product Management

Join us in the heart of Kendall Square, Cambridge to explore the future of precision medicine with single-cell multiomics. Learn how single-cell multiomics analysis can unlock earlier, deeper understanding of cancer and its treatments, and enable novel applications in the areas of hemato-oncology, MRD, genome editing, cell-based therapeutics, and more.


DATE: Monday, October 30, 2023
TIME: 10:00AM - 4:00PM

Boston Marriott Cambridge, 50 Broadway, Cambridge, MA 02142

  • – Educational presentations showcasing the latest in blood cancer therapies and translational research.
  • – Dive into the potential clinical utility and predictive power of single-cell MRD, backed by data from early-access customers.
  • – Expert views on the future of genome engineering and single-cell analysis in cancer modeling.
  • – New insights into the potential and promise of single-cell analysis for characterizing gene-edited cell therapies.
  • – Insider's look into the latest innovations from Mission Bio, featuring the Tapestri scMRD AML Multiomics Assay and the Tapestri Genome Editing Solution.
  • – And much more!



10:00a: Arrivals, Coffee & Tea

10:30a: Welcome Address, Todd Druley, MD, PhD, Mission Bio

10:45a: "Advancing Research and Therapy Development in AML & Multiple Myeloma with Single-cell DNA + Protein Multi-Omics." Todd Druley, PhD, MD, Chief Medical Officer, Mission Bio

11:15a: "Single cell methods for studying clonal evolution in myeloid malignancy." Robert Bowman, PhD, Assistant Professor, Perelman School of Medicine, University of Pennsylvania

12:00p: Lunch

1:00p: "Dissecting CRISPR/Cas9-induced genetic heterogeneity through single-cell sequencing in preclinical models of acute erythroid leukemia." Ilaria Iacobucci, PhD, Staff Scientist, St. Jude Children's Research Hospital

1:45p: Break

2:00p: "Unlocking Precision Genome Editing with the Tapestri Genome Editing Solution." Vanee Pho, PhD, Senior Director of Product Management, Mission Bio

2:30p: "Single-cell detection of multiplex CRISPR-edited gene modifications in mouse models of B cell malignancies." Elisa Ten Hacken, PhD, Assistant Professor, Weill Cornell Medical College

3:00p: Closing Remarks


Check out some of our latest posters to get a sneak peek at some of the data we'll be discussing in MRD, genome editing, multiple myeloma, and so much more!


*Our summit is free to attend. Event to include breakfast & lunch for all guests. Must register to attend. Must hold a research position at an academic institution, hospital, or pharmaceutical company to be eligible to attend.